What is Barrington Research’s Estimate for USPH Q3 Earnings?

U.S. Physical Therapy, Inc. (NYSE:USPH) – Analysts at Barrington Research raised their Q3 2025 earnings estimates for U.S. Physical Therapy in a research report issued on Friday, February 28th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $0.67 for the quarter, up from their previous estimate of $0.62. Barrington Research currently has a “Outperform” rating and a $98.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2026 earnings at $0.79 EPS.

USPH has been the topic of several other research reports. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $100.00 to $115.00 in a research report on Monday, December 16th. JMP Securities assumed coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 target price on the stock. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Finally, Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research note on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $111.50.

U.S. Physical Therapy Stock Performance

NYSE USPH opened at $79.46 on Monday. U.S. Physical Therapy has a fifty-two week low of $76.18 and a fifty-two week high of $113.63. The firm has a market capitalization of $1.20 billion, a P/E ratio of 84.53, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The stock’s fifty day moving average is $87.99 and its two-hundred day moving average is $87.62. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The company had revenue of $180.45 million during the quarter, compared to analysts’ expectations of $173.10 million.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of hedge funds have recently added to or reduced their stakes in USPH. Vanguard Group Inc. raised its stake in shares of U.S. Physical Therapy by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company’s stock valued at $96,179,000 after acquiring an additional 6,393 shares in the last quarter. Copeland Capital Management LLC raised its position in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares in the last quarter. State Street Corp boosted its stake in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares during the period. Southernsun Asset Management LLC grew its position in shares of U.S. Physical Therapy by 4.5% during the fourth quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company’s stock worth $50,725,000 after buying an additional 24,698 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of U.S. Physical Therapy by 1.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company’s stock worth $37,818,000 after buying an additional 7,890 shares during the period.

Insider Buying and Selling at U.S. Physical Therapy

In related news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.70% of the stock is owned by corporate insiders.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 14th will be issued a $0.45 dividend. This represents a $1.80 annualized dividend and a yield of 2.27%. The ex-dividend date of this dividend is Friday, March 14th. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s dividend payout ratio (DPR) is 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.